Widely prescribed blood pressure drugs linked to 33% higher kidney risk in type 2 diabetes
A widely prescribed blood pressure drug was associated with a 33% higher risk of serious kidney problems in people with type 2 diabetes, even when they were already taking kidney-protective medications. The surprising finding is prompting researchers to question whether DCCBs are always the safest second-line choice for diabetic kidney disease.
BlogZone shows headlines and summaries from public news feeds. The full story is published by ScienceDaily Health.
Read the full story at ScienceDaily Health →Enjoyed this?
Get more stories like this — and write your own — in the BlogZone app.

